ask="12.250"
ask_size="900"
average_daily_volume="10167"
bid="5.150"
bid_size="100"
book_value="2.911"
change="+0.061"
change_from_200_day_moving_average="-0.646"
change_from_50_day_moving_average="-0.797"
change_from_52_week_high="-4.619"
change_From_52_week_low="2.111"
change_in_percent="+0.656%"
close="9.361"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.643"
ebitda="0.00"
eps_estimate_current_year="-1.990"
eps_estimate_next_quarter="-0.540"
eps_estimate_next_year="-1.850"
ex_dividend_date="N/A"
float_shares="3574000"
high="9.500"
high_52_weeks="13.980"
last_trade_date="3/2/2017"
last_trade_price="9.361"
last_trade_size="100"
last_trade_time="3:39pm"
low="9.320"
low_52_weeks="7.250"
market_capitalization="86.78M"
moving_average_200_day="10.007"
moving_average_50_day="10.158"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.750"
open="9.700"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-6.452%"
percent_change_from_50_day_moving_average="-7.850%"
percent_change_from_52_week_high="-33.040%"
percent_change_from_52_week_low="+29.117%"
previous_close="9.300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.195"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.730"
stock_exchange="NGM"
symbol="GEMP"
volume="19028"
weeks_range_52="7.250 - 13.980"
